{"name": "Asuragen",
 "permalink": "asuragen",
 "crunchbase_url": "http://www.crunchbase.com/company/asuragen",
 "homepage_url": "http://www.asuragen.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "Asuragen",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "support@asuragen.com",
 "phone_number": "1-877-777-1874",
 "description": "",
 "created_at": "Sat Mar 13 03:46:24 UTC 2010",
 "updated_at": "Thu Jun 06 10:52:15 UTC 2013",
 "overview": "\u003Cp\u003EAsuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen\u00e2\u20ac\u2122s current diagnostics product portfolio consists of Signature\u00c2\u00ae Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA\u00c2\u00ae technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       51],
      "assets/images/resized/0008/0176/80176v1-max-150x150.jpg"],
     [[182,
       63],
      "assets/images/resized/0008/0176/80176v1-max-250x250.jpg"],
     [[182,
       63],
      "assets/images/resized/0008/0176/80176v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$75M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.asuragen.com/pdfs/1000-0064%20-%20Series%20B%20Financing.pdf",
    "source_description": "Asuragen, Inc. Raises $18.5 Million in Series B Financing",
    "raised_amount": 18500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 12,
    "funded_day": 10,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "PTV Sciences",
         "permalink": "ptv-sciences",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0005/2716/52716v1-max-150x150.jpg"],
             [[250,
               71],
              "assets/images/resized/0005/2716/52716v1-max-250x250.jpg"],
             [[258,
               74],
              "assets/images/resized/0005/2716/52716v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Telegraph Hill Partners",
         "permalink": "telegraph-hill",
         "image":
          {"available_sizes":
            [[[111,
               74],
              "assets/images/resized/0004/8656/48656v1-max-150x150.jpg"],
             [[111,
               74],
              "assets/images/resized/0004/8656/48656v1-max-250x250.jpg"],
             [[111,
               74],
              "assets/images/resized/0004/8656/48656v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Growth Capital Fund",
         "permalink": "growth-capital-fund",
         "image": null},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://asuragen.com/pdfs/49million.pdf",
    "source_description": "Newly Launched Asuragen Closes Series A Funding of $49 million",
    "raised_amount": 49000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 6,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Telegraph Hill Partners",
         "permalink": "telegraph-hill",
         "image":
          {"available_sizes":
            [[[111,
               74],
              "assets/images/resized/0004/8656/48656v1-max-150x150.jpg"],
             [[111,
               74],
              "assets/images/resized/0004/8656/48656v1-max-250x250.jpg"],
             [[111,
               74],
              "assets/images/resized/0004/8656/48656v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Growth Capital Fund",
         "permalink": "growth-capital-fund",
         "image": null},
       "person": null}]},
   {"round_code": "partial",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1358480/000135848013000004/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 7500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 3,
    "funded_day": 20,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2150 Woodward St., Suite 100",
    "address2": "",
    "zip_code": "78744",
    "city": "Austin",
    "state_code": "TX",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        104],
       "assets/images/resized/0008/0177/80177v1-max-150x150.jpg"],
      [[250,
        174],
       "assets/images/resized/0008/0177/80177v1-max-250x250.jpg"],
      [[450,
        314],
       "assets/images/resized/0008/0177/80177v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}